TCL Archive NCI, DOE Working Out Details Of Converting Portion Of Idaho Facility to Work On BNCT July 1, 1988
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Herceptin With Chemo Increases Survival In Early-Stage Breast Cancer, Study Finds December 30, 2005
